Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma

Clinical trial NCT07102901 · RECRUITING

Trial details

NCT number: NCT07102901
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Gastric Cancer Metastatic Gastric Cancer Gastroesophageal Junction Adenocarcinoma

Start date: 2025-09-05
Primary completion: 2027-12-01
Enrollment: 351

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.